Health states | Caregivers (N = 47) | Non-caregivers (N = 111) | Difference | t statistic | p-value | ||||
---|---|---|---|---|---|---|---|---|---|
n | Mean (SD) | Min-Max | n | Mean (SD) | Min-Max | ||||
Study 2 | |||||||||
A. Adult ADHD, receiving treatment, responder | 47 | 0.87 (0.11) | 0.45-0.95 | 111 | 0.80 (0.19) | −0.05-0.95 | 0.06 (0.17) | 2.7 | <0.01 |
B. Adult ADHD, receiving treatment, non-responder | 47 | 0.75 (0.21) | 0.05-0.95 | 111 | 0.65 (0.30) | −0.75-0.95 | 0.10 (0.28) | 2.5 | 0.02 |
C. Adult ADHD, untreated | 47 | 0.73 (0.23) | 0.05-0.95 | 111 | 0.64 (0.30) | −0.65-0.95 | 0.10 (0.28) | 2.2 | 0.03 |
Study 3 | |||||||||
A. Basic HS (stable schizophrenia, no adverse events) | 29 | 0.68 (0.35) | −0.55-0.95 | 97 | 0.56 (0.45) | −0.75-0.95 | 0.11 (0.43) | 1.3 | 0.21 |
B. Basic HS + metabolic syndrome | 29 | 0.62 (0.35) | −0.55-0.95 | 97 | 0.44 (0.49) | −0.85-0.95 | 0.18 (0.46) | 1.9 | 0.06 |
C. Basic HS + weight gain | 29 | 0.64 (0.36) | −0.55-0.95 | 97 | 0.51 (0.47) | −0.85-0.95 | 0.12 (0.45) | 1.3 | 0.19 |
D. Basic HS + diabetes | 29 | 0.58 (0.39) | −0.55-0.95 | 97 | 0.43 (0.50) | −0.95-0.95 | 0.15 (0.48) | 1.5 | 0.13 |
E. Basic HS + hyperlipidemia | 29 | 0.61 (0.38) | −0.55-0.95 | 97 | 0.47 (0.47) | −0.85-0.95 | 0.13 (0.45) | 1.4 | 0.16 |
F. Basic HS + male sexual dysfunction† | 12 | 0.57 (0.29) | 0.05-0.95 | 48 | 0.47 (0.45) | −0.85-0.95 | 0.11 (0.43) | 0.8 | 0.44 |
G. Basic HS + female sexual dysfunction† | 17 | 0.61 (0.43) | −0.55-0.95 | 49 | 0.45 (0.52) | −0.75-0.95 | 0.16 (0.50) | 1.2 | 0.25 |
H. Basic HS + male increased prolactin levels† | 12 | 0.62 (0.27) | 0.05-0.95 | 48 | 0.44 (0.47) | −0.85-0.95 | 0.17 (0.44) | 1.7 | 0.10 |
I. Basic HS + female increased prolactin levels† | 17 | 0.63 (0.41) | −0.55-0.95 | 49 | 0.44 (0.50) | −0.75-0.95 | 0.19 (0.48) | 1.4 | 0.17 |
J. Basic HS + akathisia | 29 | 0.62 (0.35) | −0.55-0.95 | 97 | 0.43 (0.51) | −0.85-0.95 | 0.19 (0.48) | 2.3 | 0.03 |
K. Basic HS + tardive dyskinesia | 29 | 0.47 (0.49) | −0.85-0.95 | 97 | 0.25 (0.60) | −0.95-0.95 | 0.22 (0.58) | 1.8 | 0.07 |
L. Basic HS + other extrapyramidal symptoms | 29 | 0.41 (0.52) | −0.85-0.95 | 97 | 0.25 (0.57) | −0.95-0.95 | 0.16 (0.56) | 1.4 | 0.17 |
M. Basic HS + insomnia | 29 | 0.65 (0.38) | −0.55-0.95 | 97 | 0.49 (0.47) | −0.85-0.95 | 0.16 (0.45) | 1.7 | 0.09 |
N. Basic HS + somnolence | 29 | 0.64 (0.36) | −0.55-0.95 | 97 | 0.48 (0.47) | −0.85-0.95 | 0.16 (0.44) | 1.7 | 0.10 |
O. Basic HS + nausea | 29 | 0.62 (0.44) | −0.65-0.95 | 97 | 0.50 (0.48) | −0.95-0.95 | 0.11 (0.47) | 1.1 | 0.26 |
P. Basic HS + vomiting | 29 | 0.65 (0.36) | −0.55-0.95 | 97 | 0.45 (0.51) | −0.95-0.95 | 0.20 (0.48) | 2.4 | 0.02 |